Overruled: No More Dual Pricing

Pharmaceutical Executive

Pharmaceutical Executive, Pharmaceutical Executive-07-01-2001, Volume 0, Issue 0

European Union-The European Commission’s ban on GlaxoSmith–Kline’s dual pricing policy in Spain halts one of Big Pharma’s attempts to prevent parallel imports in Europe.